# A First-in-Human Phase I Trial of OX118 in Healthy Volunteers

> **NCT07020156** · PHASE1 · RECRUITING · sponsor: **Oxion Biologics AB** · enrollment: 32 (estimated)

## Conditions studied

- Immune System

## Interventions

- **DRUG:** OX118 or placebo

## Key facts

- **NCT ID:** NCT07020156
- **Lead sponsor:** Oxion Biologics AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-03
- **Primary completion:** 2025-10-29
- **Final completion:** 2025-10-29
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07020156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07020156, "A First-in-Human Phase I Trial of OX118 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07020156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*